Sonnet BioTherapeutics Holdings Inc. is a biotechnology company that develops innovative cancer therapies. Their proprietary platform leverages a unique approach to create targeted and more effective treatments. With a strong focus on research and development, Sonnet BioTherapeutics aims to improve patient outcomes and make a significant impact in the fight against cancer.
